![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/519 | |
A61K 39/395 | |||
A61K 31/44 | |||
C07K 16/28 | |||
A61K 39/00 | |||
A61P 35/00 | |||
A61K 31/4704 | |||
A61K 45/06 |
(11) | Number of the document | 2804609 |
(13) | Kind of document | T |
(96) | European patent application number | 13701040.1 |
Date of filing the European patent application | 2013-01-18 | |
(97) | Date of publication of the European application | 2014-11-26 |
(45) | Date of publication and mention of the grant of the patent | 2018-06-13 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2013/050973 |
Date | 2013-01-18 |
(87) | Number | WO 2013/107883 |
Date | 2013-07-25 |
(30) | Number | Date | Country code |
12151993 | 2012-01-20 | EP |
(72) |
GUSTAVSSON, Bengt, SE
CARLSSON, Björn, SE
|
(73) |
Isofol Medical AB,
Biotech Center Arvid Wallgrens Backe 20, 413 46 Göteborg,
SE
|
(54) | TETRAHYDROFOLATES IN COMBINATION WITH EGFR-INHIBITORS |
TETRAHYDROFOLATES IN COMBINATION WITH EGFR-INHIBITORS |